Chemistry and biochemistry of type 2 diabetes

被引:292
作者
Ross, SA [1 ]
Gulve, EA [1 ]
Wang, MH [1 ]
机构
[1] Pharmacia Corp, Dept Cardiovasc & Metab Dis, St Louis, MO 63167 USA
关键词
D O I
10.1021/cr0204653
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
The insulin signaling pathways have been the central focus in order to understand how insulin regulates hepatic glucose production and peripheral glucose utilization. Major advances have been made in the past decade. By binding to its receptor, insulin triggers a cascade of phosphorylation and activation events that lead to the activation of glucose transport and the suppression of hepatic glucose production. The defective regulation of these pathways by insulin in the disease state has been under intense scrutiny using animal models that mimic certain aspects of type 2 diabetes. These models, although with limitations, have been important tools in understanding the individual aspects of the disease and defining the pathways mediating insulin resistance. The new knowledge gained further advances the understanding of the pathophysiology of the disease so that better prevention and treatment approaches can be developed.
引用
收藏
页码:1255 / 1282
页数:28
相关论文
共 375 条
[11]  
ALBU J, 1995, DIABETES REV, V3, P335
[12]   Altered expression levels and impaired steps in the pathway to phosphatidylinositol 3-kinase activation via insulin receptor substrates 1 and 2 in Zucker fatty rats [J].
Anai, M ;
Funaki, M ;
Ogihara, T ;
Terasaki, J ;
Inukai, K ;
Katagiri, H ;
Fukushima, Y ;
Yazaki, Y ;
Kikuchi, M ;
Oka, Y ;
Asano, T .
DIABETES, 1998, 47 (01) :13-23
[13]  
[Anonymous], 1976, Am J Ophthalmol, V81, P383
[14]   ALTERNATIVE PATHWAY OF INSULIN SIGNALING IN MICE WITH TARGETED DISRUPTION OF THE IRS-1 GENE [J].
ARAKI, E ;
LIPES, MA ;
PATTI, ME ;
BRUNING, JC ;
HAAG, B ;
JOHNSON, RS ;
KAHN, CR .
NATURE, 1994, 372 (6502) :186-190
[15]   Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity [J].
Arita, Y ;
Kihara, S ;
Ouchi, N ;
Takahashi, M ;
Maeda, K ;
Miyagawa, J ;
Hotta, K ;
Shimomura, I ;
Nakamura, T ;
Miyaoka, K ;
Kuriyama, H ;
Nishida, M ;
Yamashita, S ;
Okubo, K ;
Matsubara, K ;
Muraguchi, M ;
Ohmoto, Y ;
Funahashi, T ;
Matsuzawa, Y .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1999, 257 (01) :79-83
[16]   Pioglitazone hydrochloride monotherapy improves glycemic control in the treatment of patients with type 2 diabetes - A 6-month randomized placebo-controlled dose-response study [J].
Aronoff, S ;
Rosenblatt, S ;
Braithwaite, S ;
Egan, JW ;
Mathisen, AL ;
Schneider, RL .
DIABETES CARE, 2000, 23 (11) :1605-1611
[17]   Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus - A randomized controlled trial [J].
Backonja, M ;
Beydoun, A ;
Edwards, KR ;
Schwartz, SL ;
Fonseca, V ;
Hes, M ;
LaMoreaux, L ;
Garofalo, E .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 280 (21) :1831-1836
[18]   BIGUANIDES AND NIDDM [J].
BAILEY, CJ .
DIABETES CARE, 1992, 15 (06) :755-772
[19]   Inhibition of dipeptidyl peptidase IV with NVP-DPP728 increases plasma GLP-1 (7-36 amide) concentrations and improves oral glucose tolerance in obese Zucker rats [J].
Balkan, B ;
Kwasnik, L ;
Miserendino, R ;
Holst, JJ ;
Li, X .
DIABETOLOGIA, 1999, 42 (11) :1324-1331
[20]   Effects of adenoviral gene transfer of wild-type, constitutively active, and kinase-defective protein kinase C-λ on insulin-stimulated glucose transport in L6 myotubes [J].
Bandyopadhyay, G ;
Kanoh, Y ;
Sajan, MP ;
Standaert, ML ;
Farese, RV .
ENDOCRINOLOGY, 2000, 141 (11) :4120-4127